NHI price review for bio equivalent drugs shortened within a month .

Published: 2002-11-14 07:00:00

Updated: 2002-11-14 07:00:00

The KFDA, in the brief talk meeing with the HIRA on Nov. 8, decided to give additional benefit plans to the 30% incentive program for the pharmacists who substitute prescriptions for other bio equivalent drugs to boost their substitutive dispensing practices and to save the NHI finance.

The KF...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK